Publications by authors named "John Constant"

Claim this Profile
B
Bayesian approaches in drug development: continuing the virtuous cycle.
Wilmar Igl, John Constant

Nat Rev Drug Discov· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rethinking, reducing, and refining the classical oral tyramine challenge test of monoamine oxidase (MAO) inhibitors.
Ewoud-Jan van Hoogdalem, Karen L Smith, Jan Hartstra, John Constant

Clin Transl Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology-Guided Rule-Based Adaptive Dose Escalation in First-in-Human Studies.
Ewoud-Jan van Hoogdalem, Mattheus Thijs van Iersel, Erica Winter, John Constant, Martin Kappler

Clin Pharmacol Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Science-based Ethnic Bridging in Drug Development; Review of Recent Precedence and Suggested Steps Forward.
Ewoud-Jan van Hoogdalem, John P Jones Iii, John Constant, Meguru Achira

Curr Clin Pharmacol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetrodotoxin for Moderate to Severe Cancer-Related Pain: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Trial.
Neil A Hagen, Lyne Cantin, John Constant, Tina Haller, Gilbert Blaise

Pain Res Manag· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biosimilars: where we were and where we are.
Rodeina Challand, Hazel Gorham, John Constant

J Biopharm Stat· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
Michael R Jaff, Rita A Dale, Mark A Creager, Raymond John Lipicky, John Constant

Circulation· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dementia with lewy bodies: implications for clinical trials.
Barbara Collins, John Constant, Samer Kaba, C Lynn Barclay, Erich Mohr

Clin Neuropharmacol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis